Highest-materiality recent filing
Universal Health Services stockholders elect two directors, approve pay, reject shareholder proposal
Alan B. Miller re-elected as Class III director; Nina Chen-Langenmayr elected (31.8M for, 14.1M withheld).
UHS Behavioral Health President Matthew Peterson resigns effective June 19, 2026
Matthew J. Peterson, EVP and President, Behavioral Health, resigns to pursue external career opportunity.
UHS Q1 net income $348.7M ($5.65 EPS), revenue +9.6% to $4.5B
Net income attributable to UHS $348.7M ($5.65 diluted EPS) vs $316.7M ($4.80) in Q1 2025.
UHS adds $900M in new credit facilities; $400M delayed draw term loan to fund Talkspace acquisition
Added $200M incremental revolving loan, $300M incremental term loan, and $400M delayed draw term loan on April 22, 2026.
UHS sets 2026 executive bonus targets, awards stock grants; Alan Miller gets $1.07M bonus
CEO Marc Miller target bonus 150% of base salary; CFO Steve Filton target 100%.
UHS to acquire Talkspace for $5.25/share ($835M EV) to expand virtual behavioral health
UHS will pay $5.25 per share in cash; enterprise value ~$835M, financed via existing revolving credit facility.
UHS gets new trial vacating $500M punitive damages verdict in Nevada lawsuit
Judge granted new trial based on juror misconduct; entire $500M punitive verdict expected to be vacated.
UHS CEO Marc D. Miller amends employment agreement; term set to Jan 2029
Annual salary of $1,575,000 for 2026, a 5% increase over 2025 base.
Universal Health Services issues Q3 2025 earnings release; no specific financial figures in filing
Press release dated October 27, 2025 covering Q3 2025 results was furnished as Exhibit 99.1.
UHS subsidiary hit with $500M punitive damages verdict; expects reduction to ~$14M under Nevada law
Jury awarded $4.7M compensatory and $500M punitive damages against UHS of Delaware, Inc.
Universal Health Services issues press release on July 28, 2025; no details provided in filing
Press release dated July 28, 2025 was furnished as Exhibit 99.1 to the 8-K.
UHS annual meeting elects directors, ratifies PwC, defeats annual election proposal
Warren Nimetz elected Class II director by Class A/C stockholders with 7,238,163 votes for.
UHS Q1 2025 EPS soars to $4.80 from $3.82; revenue +6.7% to $4.1B
Net income $316.7M ($4.80 diluted EPS) vs $261.8M ($3.82) in Q1 2024; adjusted EPS $4.84 vs $3.70.
UHS sets 2025 executive compensation; new employment agreements for Marc Miller and Alan Miller
2025 bonus targets: Marc Miller 150% of base ($1.5M salary), Steve Filton 100%, Edward Sim & Matthew Peterson 100% (75% on divisional income).
UHS announces earnings results; details unavailable in filing summary
Filing reports Item 2.02 results of operations; press release dated February 26, 2025.
UHS Q3 net income jumps 55% to $258.7M, EPS $3.80 vs $2.40; revenue up 11.2%
Adjusted diluted EPS of $3.71, up from $2.55 in Q3 2023; revenue rose to $3.96B from $3.56B.
UHS subsidiary's punitive damages reduced to $120M from $475M; appeal planned
Trial court ordered remittitur of punitive damages from $475M to $120M on Oct 10, 2024.
UHS issues $1B in senior secured notes, refinances $2.2B term loan facility
$500M of 4.625% notes due 2029 and $500M of 5.050% notes due 2034 issued on Sep 26, 2024.
UHS faces $360M jury verdict in Cumberland sexual misconduct case; punitive expected to be cut
Jury awarded $60M compensatory, $180M trebled damages (VCPA), $120M punitive against Cumberland and Dr. Davidow.
Universal Health Services issues $1B senior secured notes to refinance term loan
$1B in senior secured notes: $500M at 4.625% due 2029, $500M at 5.050% due 2034.
UHS Q2 EPS $4.26 vs $2.42 YoY; raises 2024 guidance; adds $1B to buyback
Q2 net income $289.2M ($4.26 diluted EPS) vs $171.3M ($2.42) YoY; adjusted EPS $4.31.
Class I directors Eileen McDonnell, Marc Miller, and Elliot Sussman each elected with 7,238,788 votes for by Class A and C stockholders.
UHS Q1 net income $261.8M ($3.82 EPS); revenue +10.8% to $3.84B
Reported EPS $3.82 vs $2.28; adjusted EPS $3.70 vs $2.34. Revenue $3.844B +10.8% YoY.
UHS subsidiary hit with $535M jury verdict in patient sexual assault case
Pavilion Behavioral Health System found liable for sexual assault of minor patient by another minor patient in 2020.
UHS sets 2024 executive bonus targets and awards RSUs to officers
Marc D. Miller (CEO) target bonus 150% of base salary; discretionary $1.04M bonus to Alan B. Miller for 2023.
UHS issues corrected Behavioral Health hospital statistics for Q4 2023
Corrected Behavioral Health stats for Q4 2023: hospitals 333 (up from 331), licensed beds 24,285 (up from 24,228).
UHS Q4 revenue $3.704B, adj EPS $3.13; FY 2024 guidance adj EPS $13-14
Q4 2023 net revenues $3.704B (+7.4% YoY); adjusted EPS $3.13 vs $3.02 in Q4 2022.
CMS approves Nevada Medicaid payment program; UHS estimates $158M net reimbursements in 2024
CMS approved the Medicaid managed care component of Nevada SDP effective Jan 1, 2024 for UHS facilities.
Universal Health Services reports Q3 2023 results; details not available
Issued press release on October 25, 2023 for third-quarter financial results.
UHS files 8-K for Q2 2023 earnings; press release content not included in analysis
Filing dated July 25, 2023, for Q2 2023 earnings; press release attached as Exhibit 99.1.
UHS shareholders re-elect directors, approve say-on-pay and 3-year frequency for future votes
Directors Alan B. Miller (Class A/C) and Nina Chen-Langenmayr (Class B/D) re-elected with large majorities.
UHS Q1 2023 net income $163.1M ($2.28 EPS); revenue $3.468B, up 5.3% YoY
Adjusted EPS $2.34 vs $2.15 YoY; adjusted EBITDA $421.1M vs $379.5M.
UHS director Lawrence Gibbs resigns from Board effective March 31, 2023
Director Lawrence S. Gibbs resigns from UHS Board effective March 31, 2023.
UHS sets 2023 bonus targets and awards long-term equity to executives
CEO Marc Miller target bonus 150% of salary; CFO Steve Filton 100%; EVPs Sim and Peterson 100% (25% corporate, 75% divisional).
Universal Health Services issues earnings press release; details not available in provided text
Filing includes Item 2.02 and Exhibit 99.1 press release dated Feb 27, 2023.
UHS EVP & President of Acute Care Marvin Pember retires; separation agreement details provided
Marvin Pember's employment ends Dec 31, 2022; he will receive $33,333/month for 12 months as severance.
UHS appoints Edward Sim as EVP & President, Acute Care, succeeding retiring Marvin Pember
Marvin Pember, EVP and President, Acute Care, plans to retire after a transition period.
Nina Chen-Langenmayr appointed as Class III Director; term expires at 2023 annual meeting; standard non-employee director compensation.
Universal Health Services files 8-K with Q2 2022 earnings press release; exhibit text not provided
Press release dated July 25, 2022 furnished under Item 2.02.
UHS slashes FY2022 guidance; Q2 adjusted EPS seen at $2.05-$2.15
Q2 2022 adjusted EPS estimated at $2.05-$2.15, well below prior expectations due to lower acute care COVID volumes.
UHS adds $700M incremental term loan, extends maturity to 2026
Ninth Amendment to credit agreement adds $700M incremental Tranche A term loan due Aug 24, 2026.
UHS annual meeting results: Singer elected despite majority withhold; incentive plan approved
Maria Singer elected Class II director with 22.5M for, 38.7M withheld; board acknowledges and supports her continued service.
UHS Q1 adjusted EPS $2.15 vs $2.44 YoY; revenue up 9.3% to $3.293B
Reported net income $153.9M ($2.02 diluted) vs $209.1M ($2.43) in Q1 2021; adjusted net income $163.5M ($2.15).
UHS revises executive and board compensation, seeks to increase share reserve by 6M
CEO Marc Miller base salary raised to $1.3M (+18%); target bonus increased to 150% of salary from 100%.
UHS reports Q4 2021 earnings; press release not provided in filing body
Filing states a press release was issued on Feb 24, 2022 for quarterly results; exhibit not included here.
On May 18, 2026, Matthew J. Peterson, Executive Vice President of the Company and President, Behavioral Health, who has been with the Company since 2019, submitted his resignation from his position with the Company, effective June 19, 2026
Lawrence S. Gibbs, a member of the Board of Directors (“Board”) of Universal Health Services, Inc. (“UHS”), has informed the Board that he has accepted a new employment opportunity which will restrict his ability to serve on UHS’ Board.
Edward H. Sim, the newly appointed Executive Vice President of the Company and President, Acute Care, whose employment commenced on December 5, 2022.
Marvin G. Pember, Executive Vice President of the Company and President, Acute Care, who has been with the Company since 2011, informed us of his intention to retire from his position after a transition period following the commencement of employment of Edward H. Sim, the newly appointed Executive Vice President of the Company and President, Acute Care, whose employment commenced on December 5, 2022.
On October 21, 2022, Marvin G. Pember , Executive Vice President of the Company and President, Acute Care, who has been with the Company since 2011, informed us of his intention to retire from his position after a transition period following the commencement of employment of Edward H. Sim, as described below.
On October 21, 2022, Marvin G. Pember , Executive Vice President of the Company and President, Acute Care, who has been with the Company since 2011, informed us of his intention to retire from his position after a transition period following the commencement of employment of Edward H. Sim, as described below.
On September 21, 2022, the Board of Directors of the Company appointed Nina Chen-Langenmayr to serve as a Class III Director of the Company.
Max materiality 0.90 · Median 0.50 · Most common event earnings